openPR Logo
Press release

Transdermal Drug Delivery Market Report Up to 2031

11-02-2021 10:05 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Visiongain Pharma

Visiongain has published a new report on Transdermal Drug Delivery Market Report 2021-2031: Forecasts by Type (Patches and Semisolid formulations), Applications (Pain Management, Central Nervous System Disorders, Hormonal Applications, Cardiovascular Diseases), End User (Homecare settings, Hospitals and clinics. PLUS Profiles of Leading Pharma Contract Manufacturing Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios.

Download Exclusive Sample of Report @ https://www.visiongain.com/report/transdermal-drug-delivery-market-2021/#download_sampe_div

The market is majorly driven by the increasing prevalence of chronic diseases, where conventional drug delivery systems, such as oral drugs have lower potency due to the hepatic first pass metabolism.

Transdermal drug delivery systems are an alternative to oral intravascular, subcutaneous and intra-mucosal routes, wherein the drugs are delivered through the skin for therapeutic use.

COVID-19 Impact on Transdermal Drug Delivery Market
Transdermal Drug Delivery Market is growing well in the period of this pandemic COViD 19, because the patients who is having chronic diseases which is mentioned above need a treatment at their home itself because the threat of this pandemic restricts the patient to visit frequently to hospitals.

Market Drivers

Rise in increase of chronic disorders and geriatric population-
- The rise in geriatric population poses risk for increase in incidence of diabetes. So aged people are more susceptible to type 2 diabetes, which are in the need of these medicines for their treatment, this in-turn will boost the growth of Transdermal Drug Delivery market.

Market Opportunities
- High occurrence of cardiovascular disorders such as hypertension makes it an attractive market for transdermal drug delivery systems.
- The market has witnessed development of new adhesive, molecular absorption enhancers, and penetration enhancers that are expected to enhance skin permeability, resulting expansion therange of drugs that are expected to be delivered through transdermal route. This enables the growth of the market.

Get Detailed TOC @ https://www.visiongain.com/report/transdermal-drug-delivery-market-2021/#download_sampe_div

Competitive Landscape
Global Transdermal drug delivery market is highly fragmented and the major players have implemented various strategies such as new product launches, expansions, agreements, joint ventures, partnerships,acquisitions and others to increase their footprints in this market. Hisamitsu Pharmaceutical (Japan), Mylan (US), UCB (Belgium), Novartis (Switzerland), GlaxoSmithKline (UK), Boehringer Ingelheim (Germany), Johnson & Johnson (US), Endo International (Ireland), and Purdue Pharma (US).

Recent Developments
• Hisamitsu is a leading company in the field of medicines for external use. The company is aninventor in the field of transdermal patches. For instance, in 2017, the firm spent over USD 14.0 million compared to USD 12.8 million in 2016 on R&D activities.

• Mylan is among the leading players in the transdermal drug delivery systems market. The company endeavours to design, develop, and manufacture high-quality, innovative transdermal drug delivery systems, such as adhesive patches. These medicines treat a variety of conditions across several therapeutic categories. In order to strengthen its position in the market, the company significantly invests in R&D activities. In 2017, the company invested USD 783.3 million in R&D accomplishments to invent and introduce new products in the market as compared to USD 826.8 million in 2016.

Request Customized Report as Per Your Requirements @ https://www.visiongain.com/contact/

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Transdermal drug delivery market and leading companies. You will find data, trends and predictions.

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: catherine.walker@visiongain.com

Catherine Walker
PR at Visiongain Inc.
Tel: + 44 0207 336 6100
USA Tel: + 1 718 682 4567
EU Tel: + 353 1 695 0006
Toll Free: 00-1-646-396-5129
Email: catherine.walker@visiongain.com
Research Insight : https://www.visiongain.com/transdermal-drug-delivery-market-analysis/

About Visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Transdermal Drug Delivery Market Report Up to 2031 here

News-ID: 2450708 • Views: 157

More Releases from Visiongain Pharma

Women’s Health Diagnostics Market Report to 2031
Visiongain has published a new report on Women’s Health Diagnostics Market Report to 2031: Forecasts by Application (Breast Cancer Testing (Mammography Systems, Breast Cancer Tumor Marker Tests. Blood Chemistries and Blood Cell Count, Biopsies, and Other Diagnostic Imaging Tests), Infectious Disease Testing (Urinary Tract Infection Testing, MRSA Testing, Hepatitis Testing, Tuberculosis Testing, and Other Infectious Disease Testing), Cervical Cancer Testing (Pap Smear and HPV Testing), Osteoporosis Testing (Bone Densitometry and
Animal Hormones Market Report Up to 2031
Visiongain has published a new report on Animal Hormones Market Report to 2031: Forecasts By Application (Growth Promoters, Performance Enhancers, and Others), By Animal (Poultry, Porcine, Livestock, Equine, Aquaculture, and Other Animals (Cats, Dogs, & Rabbits)) PLUS COVID-19 Recovery Scenarios. Download Exclusive Sample of Report @ https://www.visiongain.com/report/animal-hormones-market/#download_sampe_div COVID-19 Impact on Animal Hormones Market The COVID-19 pandemic has deleteriously affected all the countries and industries. Similarly, the animal hormones market is anticipated to take
Animal Antimicrobials and Antibiotics Market Report Up to 2031
Visiongain has published a new report on Animal Antimicrobials and Antibiotics Market Report to 2031: Forecasts By Product Type (Penicillin, Tetracycline, Sulfonamides, Quinolones, Macrolides, Cephalosporin, Amingoglycoside, and Others), By Animal Type (Companion Animals and Food-producing Animals), By Mode of Delivery (Oral powder or solutions, Injections, Premix, and Others) PLUS COVID-19 Recovery Scenarios. COVID-19 Impact on Animal Antimicrobials and Antibiotics Market: The COVID-19 pandemic has deleterious affected all the countries and industries. Similarly,
Angioplasty Balloons Market Report Up to 2031
Visiongain has published a new report on Angioplasty Balloons Market Report to 2031: Forecasts By Product Type (Normal, Drug-Eluting, and Cutting & Scoring Balloons), By Application (Coronary Artery Disease and Peripheral Artery Diseases) PLUS COVID-19 Recovery Scenarios. How has COVID-19 Impacted on Angioplasty Balloons Market COVID-19 pandemic adversely affected over 200 countries worldwide. Companies have been pressured to upsurge production capacity and raise the supply of products and other commodities. The pandemic

All 5 Releases


More Releases for Transdermal

Global Transdermal Skin Patches Market | Global Transdermal Skin Patches Industr …
The transdermal skin patches market comprises of sales of transdermal skin patches products and connected services utilize to deliver medicine to the human body through patches. The Transdermal skin patches comprise the usage of adhesive patches made up of polymers that comprises drugs. The drug from such patches are absorbed into the body and ultimately into the blood stream disregarding the drug delivery through pill, or injections. According to the
Transdermal Patch Market Report 2018: Segmentation by Product (Fentanyl Transder …
Global Transdermal Patch market research report provides company profile for Actavis, Mundipharma, Henan Lingrui Pharmaceutical, Changzhou Siyao, Rfl Pharmaceutical, Hisamitsu Pharmaceutical, Novartis, Johnson & Johnson, Teikoku Pharma, Mylan and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018
US Transdermal Patch Market Outlook 2020 Report
“US Transdermal Patch Market Outlook 2020” Report Highlights: * US Transdermal Patch Market Overview * Generic & Branded Transdermal Patches * US Transdermal Patch Market: Value Chain Analysis * US Transdermal Patch Contract Manufacturing Organization * US Transdermal Patch Clinical Pipeline Insight by Company, Indication & Phase * US Transdermal Patch Clinical Pipeline: 55 Patches * Majority Patches in Preclinical Phase: 23 Patches * Marketed Transdermal Patch Clinical Insight by Company & Indication * Marketed Transdermal Patches in
Therapeutic Landscape of Transdermal Drug Delivery Pipeline
Summary The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Transdermal Drug Delivery pipeline products. GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/3090629-transdermal-drug-delivery-medical-devices-pipeline-assessment-2018 Scope -
Transdermal Scopolamine Market Evolution / Developments
A new study by Transparency Market Research (TMR) indicates that Novartis AG, alone, contributed nearly 41.0% of the overall revenue of the global transdermal scopolamine market in 2016. Other two torch bearers in the market, namely, GlaxoSmithKline Plc and Baxter International Inc., commanded a cumulative share of 49.0% in the same year. Even though, the number of small players in the market is less, the degree of competition within the
Global Transdermal Absorption Patch Market Research Report
Latest industry research report on: Global Transdermal Absorption Patch Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts This report mainly introduces volume and value market share by players, by regions, by product type, by consumers and also their price change details. As a Detailed Analysis report, it covers all details inside analysis and opinion in Transdermal Absorption Patch industry. Complete Report Details @ https://www.marketresearchreports.biz/reports/1324598/global-transdermal-absorption-patch-detailed-analysis-report-2017-2022-market-research-reports This report splits